developing Tomorrow's innovative diagnostics

Hummingbird Diagnostics is developing liquid biopsy diagnostics for early disease detection, personalized medicine, and lifetime health monitoring based on highly disease-specific miRNA biomarkers.

mirna-based LIQUID BIOPSY DIAGNOSTICS

UPDATES ON THE LATEST DEVELOPMENTS

DX Pipeline

Explore our ground-breaking pipeline of proprietary, miRNA-based diagnostic tests from blood.

More

Publications

Learn more about genomic biomarkers and read publications from the biomarker field.

More

JOIN US

Become part of Hummingbird’s team as BTA / MTA / Biologielaborant/in

More